Effects of Nutritional, Endocrine and Metabolic State on the Development of Intravascular Coagulation Induced by Human Serum Preparations with Procoagulant Activity

1973 ◽  
Vol 29 (01) ◽  
pp. 033-049 ◽  
Author(s):  
Harry N. Antoniades ◽  
Panayotis G. Iatridis ◽  
Nelson Westmoreland ◽  
James D. Simon ◽  
Kenneth C. Hayes ◽  
...  

SummaryInjection of human serum fractions with procoagulant activity into intact rats initiated hypercoagulability, thrombosis and hemorrhage. These in vivo effects were dependent upon the nutritional, endocrine and metabolic state of the animals. Injection in fed rats produced only transient hypercoagulability. In rats fasted 48 hours, the initial hypercoagulability was followed by prolonged hypocoagulation, a decline in blood platelet count, thrombosis and hemorrhage. These effects were reversed in fasted rats by glucose injected 1 hour before the serum fractions. Alloxan-diabetic fed rats and genetically obese fed rats also exhibited enhanced susceptibility to intravascular coagulation on injection of the serum fraction. However, injection of insulin in the diabetic rats before the serum fractions greatly reduced the susceptibility of these animals. The serum fractions used in these studies exhibited potent factor XIIa-like activity in vitro. The present studies demonstrate that the in vivo clotting process can be greatly influenced by the nutritional, endocrine, and metabolic state of the animal and they provide a basis for the investigation of the factors involved.

1996 ◽  
Vol 55 (3) ◽  
pp. 263-277 ◽  
Author(s):  
Christelle Douillet ◽  
Muriel Bost ◽  
Michèle Accominotti ◽  
Françoise Borson-Chazot ◽  
Maryvonne Ciavatti

Author(s):  
Thanuja D. Herath ◽  
Gunaranjan Paturi ◽  
Christine A. Butts ◽  
Catherine E. Sansom ◽  
Marco P. Morgenstern

2018 ◽  
Vol 33 (11) ◽  
pp. 1655-1658 ◽  
Author(s):  
Camila Cristina Iwanaga ◽  
Lilian dos Anjos Oliveira Ferreira ◽  
Karine Zanoli Bernuci ◽  
Carla Maria Mariano Fernandez ◽  
Fabiana Brusco Lorenzetti ◽  
...  

2020 ◽  
Author(s):  
Thanuja D Herath ◽  
Gunaranjan Paturi ◽  
Christine A Butts ◽  
Catherine E Sansom ◽  
Marco P Morgenstern

1972 ◽  
Vol 28 (01) ◽  
pp. 031-048 ◽  
Author(s):  
W. H. E Roschlau ◽  
R Gage

SummaryInhibition of blood platelet aggregation by brinolase (fibrinolytic enzyme from Aspergillus oryzae) has been demonstrated with human platelets in vitro and with dog platelets in vivo and in vitro, using both ADP and collagen as aggregating stimuli. It is suggested that the optimal inhibitory effects of brinolase occur indirectly through the generation of plasma fibrinogen degradation products, without compromising platelet viability, rather than by direct proteolysis of platelet structures.


Sign in / Sign up

Export Citation Format

Share Document